apaflurane has been researched along with Pulmonary Disease, Chronic Obstructive in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goud, M; Haghi, M; Traini, D; Young, PM; Zhu, B | 1 |
| Bhargava, S; Bhattacharya, A; Gogtay, J; Purandare, S; Rebello, J; Singh, V; Talwar, D; Whig, J | 1 |
| Goldman, M; Martin, UJ; McElhattan, J; Ramachandran, S; Rennard, SI; Silkoff, PE; Tashkin, DP | 1 |
| Carranza-Rosenzweig, J; Crim, C; Lincourt, WR; Locantore, NW; Sheth, K; Wasserman, RL | 1 |
| Perrio, MJ; Shakir, SA; Wilton, LV | 1 |
3 trial(s) available for apaflurane and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Aerosol Propellants; Aged; Albuterol; Bronchodilator Agents; Double-Blind Method; Drug Combinations; Equipment Design; Female; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; India; Ipratropium; Lung; Male; Metered Dose Inhalers; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Therapeutic Equivalency; Time Factors; Treatment Outcome | 2016 |
Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial.
Topics: Adult; Aerosol Propellants; Aged; Aged, 80 and over; Bronchodilator Agents; Budesonide; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Follow-Up Studies; Forced Expiratory Volume; Formoterol Fumarate; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index | 2009 |
Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Patient Satisfaction; Powders; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Treatment Outcome | 2006 |
2 other study(ies) available for apaflurane and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
The formulation of a pressurized metered dose inhaler containing theophylline for inhalation.
Topics: Administration, Inhalation; Aerosol Propellants; Aerosols; Anti-Inflammatory Agents; Bronchodilator Agents; Cell Line; Chemistry, Pharmaceutical; Drug Delivery Systems; Epithelial Cells; Equipment Design; Ethanol; Humans; Hydrocarbons, Fluorinated; Inflammation Mediators; Interleukin-8; Metered Dose Inhalers; Microscopy, Electron, Scanning; Particle Size; Pressure; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; Solubility; Technology, Pharmaceutical; Theophylline; Tumor Necrosis Factor-alpha | 2015 |
A modified prescription-event monitoring study to assess the introduction of Seretide Evohaler in England: an example of studying risk monitoring in pharmacovigilance.
Topics: Adult; Aerosol Propellants; Aged; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Drug Combinations; England; Female; Fluticasone-Salmeterol Drug Combination; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Pregnancy; Product Surveillance, Postmarketing; Pulmonary Disease, Chronic Obstructive | 2007 |